Search research articles
Contact Us
Filters
Showing results (321-330 of 533) with videos related to
Page
of 54
Sort By:
Journal of Proteome Research
|
November 24, 2021
Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease
Evan E Hubbard, Lilian R Heil, Gennifer E Merrihew, et al.
Alzheimer'S Research & Therapy
|
July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutations
Simon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Acta Neuropathologica Communications
|
November 28, 2018
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease
Daniel Twohig, Elena Rodriguez-Vieitez, Sigrid B Sando, et al.
Nature Aging
|
April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease
Nicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
JAMA Neurology
|
May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Neuron
|
March 24, 2018
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
ACS Medicinal Chemistry Letters
|
May 6, 2015
Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists
Christine Yang, Jaume Balsells, Hong D Chu, et al.
Elife
|
January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
Peter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Nature Medicine
|
March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
Kanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
Nature Aging
|
March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker model
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Page
of 54
Search research articles
Search
Showing results (321-330 of 533) with videos related to
Sort By:
Page
of 54
Journal of Proteome Research
|
November 24, 2021
Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease
Evan E Hubbard, Lilian R Heil, Gennifer E Merrihew, et al.
Alzheimer'S Research & Therapy
|
July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutations
Simon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Acta Neuropathologica Communications
|
November 28, 2018
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease
Daniel Twohig, Elena Rodriguez-Vieitez, Sigrid B Sando, et al.
Nature Aging
|
April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease
Nicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
JAMA Neurology
|
May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Neuron
|
March 24, 2018
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
ACS Medicinal Chemistry Letters
|
May 6, 2015
Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists
Christine Yang, Jaume Balsells, Hong D Chu, et al.
Elife
|
January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
Peter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Nature Medicine
|
March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
Kanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
Nature Aging
|
March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker model
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Page
of 54